本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Elevation Oncology, Inc.

0.3650
0.0000
成交量:- -
成交额:- -
市值:2,162.73万
市盈率:-0.45
高:0.3650
开:0.3650
低:0.3650
收:0.3650
52周最高:3.09
52周最低:0.2210
股本:5,925.29万
流通股本:4,353.48万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.8118
每股收益(LYR):-0.7767
净资产收益率:-78.32%
总资产收益率:-29.86%
市净率:0.46
市盈率(LYR):-0.47

数据加载中...

2025/07/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/23

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/07/23

重要事件披露

Form 8-K - Current report
2025/07/03

重要事件披露

Form 8-K - Current report
2025/06/09

重要事件披露

Form 8-K - Current report
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/04

重要事件披露

Form 8-K - Current report
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/20

重要事件披露

Form 8-K - Current report
2025/03/19

重要事件披露

Form 8-K - Current report
2025/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/06

重要事件披露

Form 8-K - Current report
2025/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/31

重要事件披露

Form 8-K - Current report